Skip to main content
. 2023 Oct 25;42:281. doi: 10.1186/s13046-023-02853-4

Table 2.

Final drug concentrations, log10 [M]

Drugs [C] low [C] medium [C] high
5FU -7 -6.25 -5.5
Azacitidine -6.5 -5.75 -5
Bortesomib -9.25 -8.5 -7.75
Carboplatin -6.25 -5.5 -4.75
Cobimetinib -8 -7.25 -6.5
Docetaxel -9.25 -8.75 -8.25
Doxorubicin -8 -7.25 -6.5
Etoposide -6.75 -6 -5.25
Everolimus -8.5 -7.75 -7
Fludarabine -8 -7.25 -6.5
Gefetinib -7.5 -6.75 -6
Gemcitabine -7.5 -6.75 -6
Lapatinib -7 -6.25 -5.5
Mitomycin -8 -7.25 -6.5
Olaparib -6.5 -5.75 -5
Oxaliplatin -6.5 -5.75 -5
Paclitaxel -9 -8.5 -8
Pemetrexed -8.25 -7.5 -6.75
Raltitrexed -9 -8.5 -8
Regorafenib -6.5 -5.75 -5
SN-38 -9 -8.5 -8
Sunitinib -7 -6.5 -6
Trifluridin-tipiracil -6.5 -5.75 -5
Vinorelbine -8.75 -8 -7.25
Vorinostat -6.75 -6.25 -5.75